|
Jan 11
|
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?
|
|
Dec 21
|
Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie
|
|
Dec 19
|
Is Alpine Immune Sciences (ALPN) Stock Outpacing Its Medical Peers This Year?
|
|
Dec 18
|
Alpine Immune Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 18
|
Optimistic Investors Push Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares Up 41% But Growth Is Lacking
|
|
Dec 6
|
Wall Street Analysts See a 56.25% Upside in Alpine Immune Sciences, Inc. (ALPN): Can the Stock Really Move This High?
|
|
Nov 29
|
Is Alpine Immune Sciences (ALPN) Outperforming Other Medical Stocks This Year?
|
|
Sep 8
|
Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?
|
|
Sep 5
|
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
|
|
Sep 5
|
Alpine Immune Sciences to Present First Preclinical Data for Povetacicept in Myasthenia Gravis at the American Neurological Association Annual Meeting
|
|
Aug 24
|
Alpine Immune Sciences, Inc. (ALPN) Is a Great Choice for 'Trend' Investors, Here's Why
|
|
Aug 22
|
Alpine Immune Sciences Announces Appointment of M. Christina Yi as Chief Technology Officer and Grant under Nasdaq Listing Rule 5635(c)
|
|
Aug 17
|
Does Alpine Immune Sciences, Inc. (ALPN) Have the Potential to Rally 25.38% as Wall Street Analysts Expect?
|
|
Aug 16
|
Companies Like Alpine Immune Sciences (NASDAQ:ALPN) Are In A Position To Invest In Growth
|
|
Jul 23
|
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) surges 14%; private equity firms who own 38% shares profited along with institutions
|